Nathaniel Barnes, MD
Urology · Webster, TXNPI 1033119516
Payments from drug & device makers
Across 630 payments — averaging $526.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$188K
- Sumitomo Pharma America, Inc.$98K
- Urovant Sciences Inc$26K
- Pfizer$14K
- Boston Scientific$2K
- Coloplast$910
- plus $3K from 31 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 250 | $187,610 |
| Sumitomo Pharma America, Inc. | 174 | $97,914 |
| Urovant Sciences Inc | 44 | $26,374 |
| Pfizer | 53 | $14,084 |
| Boston Scientific | 23 | $1,855 |
| Coloplast | 13 | $910 |
| Agiliti Surgical, Inc. | 4 | $323 |
| Dornier Medtech America, Inc | 2 | $235 |
| Astellas Pharma Global Development | 4 | $194 |
| Teleflex LLC | 4 | $182 |
| Neotract Inc. | 2 | $166 |
| Olympus America Inc. | 3 | $162 |
| AbbVie | 8 | $159 |
| C. R. Bard, Inc. & Subsidiaries | 5 | $141 |
| Novo Nordisk | 1 | $116 |
| Myovant Sciences Inc. | 4 | $99 |
| Seagen Inc. | 1 | $96 |
| Bayer | 3 | $92 |
| Axonics, Inc. | 3 | $67 |
| Laborie Medical Technologies Corp. | 3 | $67 |
| Progenics Pharmaceuticals, Inc. | 2 | $62 |
| Antares Pharma, Inc. | 3 | $61 |
| Johnson & Johnson | 3 | $49 |
| 180 Medical, Inc. | 2 | $46 |
| Medtronic(2 entities) | 2 | $41 |
| Tolmar Pharmaceuticals, Inc. | 2 | $39 |
| Acerus Pharmaceuticals Corporation | 2 | $32 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Ambu Inc. | 1 | $26 |
| Healthtronics Stone Solutions, LLC | 1 | $25 |
| Cook Medical LLC | 1 | $19 |
| RGH Enterprises LLC | 1 | $19 |
| Procept Biorobotics Corporation | 1 | $19 |
| Tolmar, Inc. | 1 | $18 |
| Myriad Genetic Laboratories, Inc. | 1 | $17 |
| Travere Therapeutics, Inc. | 1 | $17 |
| Amgen | 1 | $16 |
How this compares
$331,377 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Webster
- Rohit DhirWebster$152K
- Zvi SchiffmanHouston$17.8M
- Jose de la CerdaSan Antonio$9M
- Daniel SaltzsteinSan Antonio$5.8M
- Jose KaramHouston$5.7M
- Daniel ZainfeldSan Antonio$4.7M
- Brian MazzarellaLakeway$4.5M
- Andrew von EschenbachMontgomery$3.2M
- Raj SatkunasivamHouston$2.6M
- Alan SkolnickHouston$2.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.